Allogeneic Adipose-derived Mesenchymal Stem Cells（Mayo Clinic）

N/A

Report date: 2023/03/30 20:00:23

Base Information

Drug NameAllogeneic Adipose-derived Mesenchymal Stem Cells（Mayo Clinic）
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsGlioblastomaAstrocytoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesMayo Clinic
Inactive CompaniesN/A
Active IndicationsGlioblastomaAstrocytoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A